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Abstract 
Background Prescription medication borrowing and sharing is a behaviour that has been identified in 
patients of all ages. This behaviour is recognised by medical researchers and government health 
authorities as a potential risk factor in adverse drug events across the community. Objective This article 
discusses prescription medication borrowing and sharing and identifies populations more likely to 
participate in this behaviour. It also focuses on the classes of drugs identified in the research literature as 
those being more likely to be borrowed or shared. Discussion Prescription medication borrowing and 
sharing behaviours have been associated with several risk factors such as polypharmacy and multiple 
chronic comorbidities. General practitioners and health professionals are therefore encouraged to 
counsel patients, at the time of issuing prescriptions and following discharge from hospital, on the risks 
of borrowing and sharing prescription medications and the safe disposal of ‘left over’ prescription 
medications. 
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prescription medication borrowing and sharing (pmBs) is 
a patient behaviour that negatively affects patient quality use 
of medicine.1 this behaviour is recognised by medical 
practitioners, researchers and government health authorities 
as a risk factor in medication errors which results in adverse 
drug events (aDes).2–4 Despite this, many studies examining 
the risk factors for aDes do not directly examine pmBs 
behaviour. any evidence reported usually categorises pmBs 
under the umbrella terms ‘medication error’2,4 or ‘medication 
misadventure’;5 or may be referred to obliquely as ‘use of 
inappropriate medicine’.4 the danger with this is that there is 
a risk of underestimating the impact of this behaviour on the 
incidence of aDes.  
An adverse drug event is defined as ‘harm that results from the 
intrinsic nature of a medication (an adverse drug reaction) as well 
as harm that results from medication errors associated with the 
manufacture, distribution or use of medicines’.2 ‘Borrowing’ a 
prescription medication has been defined by Goldsworthy et al3 as the 
patient taking a medication prescribed for someone else. ‘Sharing’ (or 
‘loaning’) means that the patient gives their prescribed medication to 
someone else.3
 The impact of ADEs in Australia is significant in terms of cost to 
both the government and community.2 In the Second National Report 
on Patient Safety4 it is noted that, of the 100 million general practice 
encounters every year in Australia, around 400 000 are associated 
with an ADE.4 Furthermore, it is estimated that around half of drug 
related hospitalisations in Australia are most likely preventable,5 and 
pre-admission ADEs are implicated in around half of hospitalisations.6
 It is acknowledged that, due to difficulties in collecting data 
from community based incidents, the actual number of ADEs due 
to medication error can only be estimated.2,4 Systems can be put 
in place to measure and monitor inappropriate dose or medication 
administration while a patient is under the care of health professionals 
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proportion of these people practised PMBS behaviour. Researchers 
identified several factors that facilitated this behaviour (Table 1),1 
most of which were similar to American studies.3,11 In particular, 
people in this population were more likely to share prescription 
medicine with a family member, kept ‘leftover’ medicine for ‘next 
time’ and asked their GP for the same medication that a family 
member had been prescribed.1
 Australians aged over 60 years have also been found to share, 
stockpile and hoard their prescription medications.5,15,6 The reported 
rates of elderly people stockpiling and hoarding prescription 
medicine varied from 0.9%5 to over 42%.16 It should be noted 
however, that these results are based on small studies, usually 
related to the home medicine review (HMR) process. Perhaps as 
a result of people hoarding medicines, a significant number of 
elderly respondents were found to have expired medicines in their 
home.5 Higher numbers of medications in an elderly person’s home 
(prescription and OTC medications) have been found to have a 
significant correlation with severity of illness and worsened health 
status,17 including increased risk of ADEs.17 No definitive data 
on the link between hoarding medicines and PMBS has been 
collected or reported.4
medications most likely to be borrowed or shared
Several classes of drugs (Table 2) have been identified as being 
borrowed or shared for the treatment of both acute and chronic health 
conditions. In particular, pain medications are commonly borrowed 
or shared, including nonsteroidal anti-inflammatory agents (NSAIDs) 
and the stronger opioids.12,18,19 Antibiotics also appear to be major 
contributors to borrowing and sharing behaviours.
 The use of NSAIDS have been implicated in ‘medication 
misadventures’ due to inappropriate use or use of expired 
medications,5 behaviours which encompass PMBS. The unmonitored 
long term use of NSAIDS18 has the potential for ADEs, particularly 
drug-drug interactions with prescribed medications. Examples of 
these interactions include an exacerbation of bleeding when used in 
combination with anticoagulants (eg. heparin and warfarin),2,5 and 
cardiac complications when used in combination with cardiovascular 
medications (eg. antihypertensives and digoxin).2,5
in a hospital setting; however, this is more difficult when a patient 
is at home. One major issue reported in research literature is 
changes to patient medication regimens during hospitalisation and 
how these changes are communicated to the patient’s primary care 
physician through the discharge summary.7 There is a possibility that 
complications may arise: for example, if a medication is discontinued 
the patient may not be counselled about correctly disposing of 
leftover medications at home, this may lead to possible hoarding of 
prescription medications, which in turn can facilitate PMBS behaviour 
and possible ADEs due to the availability of ‘spare’ medication.
 Literature and reviews on ADEs in hospital and ambulatory care 
have pinpointed several risk factors for ADEs. These include the 
increased age of the patient, multiple medications (polypharmacy), 
and an increased number of chronic, comorbid conditions.2,5,8–10 As 
there is no complete, reliable, single source of data,2 due in part 
to there being no centralised reporting system for ‘minor’ ADEs (ie. 
those that do not cause fatalities nor lasting morbidity),8,10 there may 
be more risk factors that have not yet been identified.
Different populations
Research has found PMBS behaviour is prevalent across all 
ages.3,11,12 There are similar issues with PMBS in all ages; however, 
there are also age specific and cultural issues which have been 
identified.
 Patients who self medicate appropriately with over-the-counter 
(OTC) medications are the main focus of research studies.12–14 In 
general, this behaviour is considered benign, although a subgroup of 
‘unsafe self medicators’ has been described in a survey of Spanish 
participants aged 16 years and over.12 This description refers to the 
taking of prescription or restricted medicines without professional 
medical supervision12 and it is assumed that this behaviour also 
includes PMBS. In this study, the characteristics of these ‘unsafe self 
medicators’ included female gender, living alone, being retired and 
being older.12
 Very few studies since 2000 focus directly on PMBS behaviour. 
Two American studies looked at populations aged 12–44 years. In 
both studies it was found that around one-quarter of respondents 
reported sharing or borrowing prescription medications;3,11 usually 
asthma,11 allergy, pain relief3 and antibiotic medications3 (Table 1). 
The incidence of this behaviour was higher in those aged 18–35 
years,3 peaking in the early 20s.11
 In a review of medication use among older Australians it was 
found that 13–20% reported sharing prescription medications.15 In 
common with the younger populations previously discussed,3,11 older 
Australians were willing to share medication(s) previously prescribed 
for them if they had run out of that medication.15 Borrowing ‘new’ 
medication was not as acceptable, with only 2% reporting to have 
borrowed a prescription drug never prescribed for them.15
 A recent small, qualitative Australian study looking at medication 
management habits of non-English speaking background (Chinese 
and Arabic) residents in southwestern Sydney found that a significant 
Table 1. Conditions facilitating PMBS, as identified in  
research literature
More likely to share with a family member
Share with someone else, if they had the same prescription
Borrower had run out of prescription medicine in the short term
Wanting to ‘help a friend’
Had ‘leftover’ medicine – kept deliberately for ‘next time’
Non-English speaking background
More people in the house
Single (not in a relationship)
Wanting same medication as other family member
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impacts of PMBS behaviour. Other impacts related to patient 
perception of the effectiveness of medication treatments or physician 
care are less often discussed and are more difficult to manage.
Discussion
Several risk factors and characteristics have been identified which 
may be associated with PMBS behaviours, providing a theoretical 
picture of a patient who is more likely to borrow or share prescription 
medications (Table 1). 
 Prescription medication borrowing and sharing is acknowledged 
as being commonplace among patients; however, possibly due to the 
difficulties in collecting data on ADEs occurring in the community, little 
evidence has been collected on the prevalence and the incidence of this 
behaviour associated with ADEs. Further research into PMBS behaviour 
in elderly patients and those with chronic comorbid health conditions in 
particular, needs to be conducted as this group are at most risk of poor 
health outcomes or ADEs as a result of this behaviour. 
 General practitioners and other health professionals should be 
proactive in helping patients manage their prescription medications 
safely. In every day practice strategies such as education, and 
encouragement and reinforcement to discourage the practice of 
borrowing and sharing prescribed medications should be considered.
 Patients recently discharged from hospital should have their 
current medication regimens reconciled. That is, a check of the 
medications listed on the patient’s discharge summary should be 
made and the patient consulted to determine which medications 
are still being taken, and that the patient is managing their new 
medication regimen safely having appropriately discarded 
medications no longer required.
 Patients should also be counselled at the time of prescribing, 
especially the identified ‘at risk’ medications (eg. antibiotics, NSAIDs, 
strong painkillers), that these medications are for their use only and 
that they should not be shared with family or friends. Likewise, any 
changes to a patient’s medication regimens should include discussion 
about how patients should safely dispose of unwanted leftover 
prescription medications.
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